Overview

Stress urinary incontinence affects a significant proportion of women — particularly those who have had vaginal deliveries, and those in whom the hormonal changes of the perimenopause and menopause have reduced the tone and elasticity of the pelvic floor connective tissue. It is characterised by involuntary urine leakage during moments of increased intra-abdominal pressure — a cough, a laugh, a sneeze, a run, a jump. The mechanism is a failure of the urethral support system: the connective tissue of the anterior vaginal wall, the periurethral fascia, and the pelvic floor structures that provide structural support for the urethra and bladder neck are no longer able to maintain urethral closure against the sudden pressure increase.

The experience of living with stress urinary incontinence is one that many women compartmentalise — wearing absorbent protection as a routine measure, avoiding certain exercises and social situations, managing rather than addressing the underlying concern. The limitation is real, the embarrassment is real, and the reduction in quality of life is real. What is also real — and far less widely known — is that an effective, non-surgical treatment exists that addresses the structural cause of the condition directly, through the same laser collagen remodelling technology used in the IntimaLase vaginal tightening protocol.

IncontiLase uses the Fotona SP Dynamis Er:YAG laser — delivered through a specifically positioned applicator targeting the anterior vaginal wall and periurethral tissue — to stimulate collagen remodelling in the structural support tissue of the urethra and bladder neck. Multiple randomised controlled trials have demonstrated statistically significant reduction in stress urinary incontinence episodes following a course of IncontiLase treatment, with high patient satisfaction and an excellent safety profile. The treatment requires no anaesthetic, produces no surface wound, and imposes no recovery period beyond 7 days of intimate activity avoidance.

What IncontiLase Actually Does

The structural basis of stress urinary incontinence lies in the collagen quality and arrangement of the periurethral connective tissue — the tissue that provides the support mechanism preventing urethral opening under pressure. When the collagen framework of this tissue is damaged by vaginal delivery or depleted by hormonal change, the support mechanism is compromised and the urethra cannot maintain closure against sudden intra-abdominal pressure increases. IncontiLase addresses this structural basis directly. The Er:YAG laser energy, delivered at precisely calibrated parameters to the anterior vaginal wall and periurethral tissue, produces a controlled thermal stimulus in the submucosal connective tissue at this specific anatomical location.

The thermal stimulus initiates the same two-phase biological response that characterises all collagen remodelling with the Fotona laser: immediate collagen fibre contraction — physically tightening the periurethral support structure — and progressive collagen neostimulation over 3–6 months, as fibroblasts activated by the thermal stimulus produce new collagen that gradually improves the structural integrity and tone of the support tissue. The result is a progressive restoration of the mechanical support that prevents involuntary urethral opening under pressure — achieved through biology rather than surgery.